DrugDashboards

Olanzapine

Olanzapine · OLANZAPINE 7.5 mg/1 · Tablet · Oral · Aurobindo Pharma Limited

NDC 65862-0563-99 · 1000 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 14% over the past year, to $0.0902 per unit. The brand (Zyprexa) runs $33.27 per unit — 309× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0902per EAinvoice-surveyed acquisition cost · Aug 20, 2025
  • Part D plans paid (avg)$2.33per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0891per TABweighted avg manufacturer price $0.0419 · May 1, 202599% of what pharmacies pay — a deeper discount than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Nov 2013Aug 2025$0.0902
143 price points · per EA · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.71
#90 count
$8.12

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$145
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olanzapine (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $31.43 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Zyprexa Relprevv

Regulatory

Application
ANDA202050
TE code
AB
Approval date
Apr 23, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olanzapine (Tablet)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedOLANZAPINE 10 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 3, 2026
Ascend Laboratories, LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olanzapine — NDC 65862-0563-99," retrieved September 3, 2026, https://drugdashboards.com/drug/65862056399.

Free to cite with attribution — see how the data is put together.